Against the backdrop of stricter hospital infection control and full implementation of DRG medical payment reform, the laparoscopic cannula industry has split into two distinct segments: single-use sterile cannulas and reusable sterilizable cannulas. Leading domestic and overseas manufacturers formulate differentiated development strategies based on their production capacity, technological strengths and channel resources. The two product types complement each other in safety, economic efficiency, operational cost and infection risk, jointly forming a complete market landscape of minimally invasive consumables in China.

Reusable laparoscopic cannulas are mainly made of medical stainless steel and titanium alloy, dominated by premium international brands including Johnson & Johnson, Stryker and Karl Storz. Featuring robust structure and outstanding wear resistance, these products can be reused multiple times after standard high-temperature and high-pressure sterilization in Central Sterile Supply Department. They carry low amortized cost per operation and are well-suited for tertiary public hospitals with large and steady surgical volume. Bulk long-term application effectively cuts overall consumable expenses and meets intensive management demands of large medical departments. Nevertheless, reusable cannulas require rigorous whole-process management covering cleaning, disinfection, sterilization and inspection, resulting in high labor and time costs. Non-standard sterilization procedures may pose potential cross-infection risks, placing stringent requirements on hospital infection management capability.

Single-use laparoscopic cannulas are integrally molded from medical polymers and individually packaged in sterile condition. Designed for one-time single-patient use and immediate disposal after operation, they completely eliminate cross-infection hazards, making them the preferred option for primary hospitals, emergency surgeries and day-case surgeries. Homegrown industry leaders such as Mindray Medical, Kangji Medical and WEGO Group have long specialized in disposable products. Their cannulas deliver imported-equivalent performance in sealing property, puncture safety and pneumoperitoneum stability with remarkable price advantages. Disposable cannulas exempt hospitals from cleaning and disinfection work, streamline operating room procedures, shorten preoperative preparation time and ease infection management burden, perfectly adapting to DRG cost control and rapid turnover of day-case surgeries. The main drawback lies in higher cumulative consumable expenditure under frequent long-term use compared with reusable devices.

Most domestic hospitals adopt a mixed utilization mode. Titanium alloy and stainless steel reusable cannulas are applied in complex prolonged Grade III and IV surgeries to ensure stable high-intensity operation, while disposable cannulas are adopted for routine day-case procedures, minor gynecological surgeries and emergency minimally invasive operations. International brands are expanding presence in the disposable consumable market to broaden coverage. Domestic enterprises strive to make breakthroughs in high-end stainless steel and titanium alloy reusable cannula technologies, breaking foreign monopoly in the premium segment.

The industry evolves toward prioritized safety, controllable cost and standardized infection prevention. Manufacturers adopt dual-track layout. The market penetration rate of disposable cannulas keeps rising, and domestic substitution of high-end reusable products accelerates. The continuous optimization of laparoscopic consumable market facilitates standardized development of minimally invasive surgical services across medical institutions of all levels.